Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pertussis
Rotavirus
NITAG documentation
2020
Clear all
Type of publications
NITAG documentation
(84)
SAGE documentation
(2)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(138)
Topics
Agenda & Minutes
(9)
Background paper
(48)
Functioning
(1)
Recommendation
(26)
Available to download in languages
English (EN)
(66)
French (FR)
(10)
Spanish (ES)
(9)
Regions
Africa
(2)
Americas
(63)
Europe
(16)
South-East Asia
(1)
Western Pacific
(2)
Countries
Diseases
COVID-19
(82)
Pertussis
(1)
Rotavirus
(1)
Diphtheria
(1)
Ebola
(3)
Hepatitis A
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(6)
Influenza
(8)
Meningococcal disease
(1)
Pneumococcal disease
(3)
Poliomyelitis
(2)
Tetanus
(1)
Tuberculosis
(1)
Typhoid
(1)
Yellow fever
(1)
Vaccine topics
Target population
Healthcare workers
(3)
Older adults
(2)
Risk group
(3)
Publication date
2020
(84)
2024
(7)
2023
(28)
2022
(75)
2021
(167)
2019
(6)
2018
(6)
2017
(6)
2016
(5)
2015
(6)
2014
(9)
2013
(2)
2012
(3)
2011
(1)
2010
(7)
2009
(3)
2008
(4)
2006
(4)
2005
(1)
2004
(1)
84 results found
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI Interim statement on target groups for vaccination against SARS-COV-2
2020
∙
CAVEI
CAVEI ordinary meeting August 26th 2020
2020
∙
CAVEI
CAVEI ordinary meeting August 5th 2020
2020
∙
CAVEI
CAVEI ordinary meeting July 29th 2020
2020
∙
CAVEI
CAVEI ordinary meeting June 24th 2020
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI recommendations to prioritize vaccination against SARS-COV-2 in health personnel during the campaign initiation phase and in the context of vaccine limited supply
2020
∙
Steve Anderson
CBER Plans for Monitoring COVID-19 Vaccine Safety and Effectiveness
2020
∙
Tom Shimabukuro, ACIP
CDC post-authorization/post-licensure safety monitoring of COVID-19 vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register